HUMAN HEALTH HOLDINGS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.98 HKD | -4.85% |
|
-2.00% | -18.33% |
| Feb. 27 | Human Health Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
| Feb. 08 | Human Health Warns of Significant Decline in Fiscal H1 Profit | MT |
| Sales 2022 | 1.12B 143M | Sales 2023 | 1B 128M | Capitalization | 721M 92.08M |
|---|---|---|---|---|---|
| Net income 2022 | 375M 47.88M | Net income 2023 | 181M 23.11M | EV / Sales 2022 | 0.47 x |
| Net cash position 2022 | 95.42M 12.18M | Net cash position 2023 | 459M 58.58M | EV / Sales 2023 | 0.26 x |
| P/E ratio 2022 |
1.65
x | P/E ratio 2023 |
3.99
x | Employees | 588 |
| Yield 2022 |
18.4% | Yield 2023 |
8.42% | Free-Float | 31.58% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -4.85% | ||
| 1 week | -2.00% | ||
| Current month | -2.00% | ||
| 1 month | -3.92% | ||
| 3 months | -15.52% | ||
| 6 months | -26.87% | ||
| Current year | -18.33% |
1 week
0.98
1.05
1 month
0.981.05
Current year
0.901.25
1 year
0.902.07
3 years
0.832.40
5 years
0.522.40
10 years
0.523.51
| Managers | Title | Age | Since |
|---|---|---|---|
Lai Sheung Pang
FOU | Founder | 57 | 97-07-07 |
Kin Ping Chan
CEO | Chief Executive Officer | 60 | 97-07-07 |
Tin Wai Chan
DFI | Director of Finance/CFO | 60 | 23-01-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yue Kwong Chan
BRD | Director/Board Member | 72 | 16-01-26 |
Sun Wing Lui
BRD | Director/Board Member | 74 | 16-01-26 |
Kar Tim Sin
BRD | Director/Board Member | 68 | 16-01-26 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 0.98 | -4.85% | 116,000 |
| 24-04-18 | 1.03 | 0.00% | 0 |
| 24-04-17 | 1.03 | +3.00% | 150,000 |
| 24-04-16 | 1 | 0.00% | 54,000 |
| 24-04-15 | 1 | 0.00% | 22,000 |
Delayed Quote Hong Kong S.E., April 19, 2024 at 04:08 am EDT
More quotes
Human Health Holdings Limited is a private integrated healthcare service provider in Hong Kong with comprehensive outpatient capabilities covering general practice services, specialties services and dental services. The Company's general practice services include a broad range of family medicine related healthcare services such as general consultation, diagnostic and preventative healthcare services, treatments, minor procedures, pharmaceutical drug dispensing, vaccinations, physical check-ups, health education activities, provision of occupational health advices and work injury assessment. Its specialties services include general surgery, orthopaedics & traumatology, ophthalmology, otorhinolaryngology, paediatrics surgery, obstetrics & gynaecology, cardiology, gastroenterology & hepatology, respiratory medicine and dermatology. Its dental services comprise general dentistry, specialties dentistry and cosmetic dentistry.
Calendar
2024-09-25
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -18.33% | 47.48M | |
| -11.66% | 87.92B | |
| +12.72% | 80.7B | |
| +10.85% | 29.37B | |
| -11.36% | 16.95B | |
| -6.85% | 14.26B | |
| +0.92% | 12.2B | |
| -30.35% | 12.01B | |
| -3.53% | 11.46B | |
| +22.01% | 11.21B |
- Stock Market
- Equities
- 1419 Stock
